Publications by authors named "Sheng-Fu Cheng"

Claim this Profile
A
Accelerated versus conventional corneal collagen cross-linking for keratoconus: A meta-analysis of randomized controlled trials.
Cyuan Yi Yeh, Kuan Chieh Chen, Yen Ju Chen, Sheng Fu Cheng

Eur J Ophthalmol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influencing Factors in Corneal Densitometry Recovery After Accelerated Cross-Linking for Keratoconus.
Kuan-I Huang, Cyuan-Yi Yeh, Chao-Chien Hu, Sheng-Fu Cheng

J Ophthalmol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urothelial Dysfunction and Chronic Inflammation are Associated With Increased Bladder Sensation in Patients With Chronic Renal Insufficiency.
Sheng-Fu Cheng, Yuan-Hong Jiang, Hann-Chorng Kuo

Int Neurourol J· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical ranibizumab as a treatment of corneal neovascularization.
Giulio Ferrari, Mohammad H Dastjerdi, Andre Okanobo, Sheng-Fu Cheng, Francisco Amparo

Cornea· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 22967868.
Sheng-Fu Cheng, Mohammad H Dastjerdi, Giulio Ferrari, Andre Okanobo, Francisco Amparo

Am J Ophthalmol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term topical bevacizumab in the treatment of stable corneal neovascularization.
Sheng-Fu Cheng, Mohammad H Dastjerdi, Giulio Ferrari, Andre Okanobo, Kraig S Bower

Am J Ophthalmol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gamma-irradiation reduces the allogenicity of donor corneas.
William Stevenson, Sheng-Fu Cheng, Parisa Emami-Naeini, Jing Hua, Eleftherios I Paschalis

Invest Ophthalmol Vis Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).
William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, Giulio Ferrari, Reza Dana

Ocul Surf· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis